Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas (NF108-BINI)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03231306 |
Recruitment Status :
Active, not recruiting
First Posted : July 27, 2017
Last Update Posted : December 21, 2023
|
Sponsor:
University of Alabama at Birmingham
Collaborators:
Array BioPharma
Pacific Pediatric Neuro-Oncology Consortium
Information provided by (Responsible Party):
Bruce Korf, MD, University of Alabama at Birmingham
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 31, 2025 |
Estimated Study Completion Date : | December 31, 2026 |
Publications: